Company intelligence / Profile preview
Procare Health
- Ownership
- Private
- Employees
- ~197
- Development stage
- Commercial
Overview
Procare Health has commercialized a range of CE-marked medical devices and food supplements addressing women’s reproductive health needs across >75 countries. Its lead marketed product is Papilocare®, a patented vaginal gel to prevent/treat HPV-induced cervical lesions. The company is also developing novel therapeutic vaccines against ovarian and cervical cancers through a co-development agreement with BioVaxys; these are at preclinical or early clinical stages.
- Therapeutic areas
- Women's HealthInfectious Diseases
- Modalities
- Medical deviceFood supplementSmall moleculeVaccine
- Industry
- Biotech
Drug pipeline
11 assets10 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Procare Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Procare Health.